Traditional and Human Genome Variation Society (HGVS) Standard Nomenclature for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations and Variants Included on the Michigan Newbo

First Page		Document Content
Date: 2013-01-08 07:53:12 Mutation Channelopathy Pediatrics ΔF508 Cystic fibrosis 1G Ivacaftor Biology Health Genetics		Traditional and Human Genome Variation Society (HGVS) Standard Nomenclature for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations and Variants Included on the Michigan Newbo Add to Reading List Source URL: www.michigan.gov Download Document from Source Website File Size: 101,27 KB Share Document on Facebook

	OPEN SUBJECT AREAS: FLUORESCENCE IMAGING DRUG DEVELOPMENT HIGH-THROUGHPUT SCREENING DocID: 1pyUW - View Document
	Pulmonary-Allergy Drugs Advisory Committee Meeting Lumacaftor/Ivacaftor Tablets for oral use NDAFDA Opening Remarks and Regulatory History DocID: 1eMZq - View Document
	FDA Advisory Committee Briefing Materials ORKAMBI™ (Lumacaftor/Ivacaftor) for CF Page 1 of 98 Sponsor Briefing Document DocID: 1dX4Q - View Document
	11. On page 120, the 3rd sentence in Section 2.5 should read “In my opinion, it would be a bad idea to conclude that ivacaftor was similar to placebo and even worse to conclude that LUM/IVA was better than placebo iv DocID: 1aHHB - View Document
	PDF Document DocID: 17l0S - View Document